ArticleCancer chemotherapy and pharmacology2025
Napabucasin targets resistant triple negative breast cancer through suppressing STAT3 and mitochondrial function.
Limei Yuan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it